🇺🇸 FDA
Patent

US 7566785

Amidine substituted aryl aniline compounds

granted A61PA61P11/00A61P11/06

Quick answer

US patent 7566785 (Amidine substituted aryl aniline compounds) held by Theravance, Inc. expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P11/00, A61P11/06, A61P43/00